Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsine' expression in gliobastoma derived spheroids
ID
Ardebili, Seyed Yousef
(
Author
),
ID
Zajc, Irena
(
Author
),
ID
Gole, Boris
(
Author
),
ID
Campos, Benito
(
Author
),
ID
Herold-Mende, Christel
(
Author
),
ID
Drmota Prebil, Sara
(
Author
),
ID
Lah Turnšek, Tamara
(
Author
)
URL - Presentation file, Visit
http://www.dlib.si/details/URN:NBN:SI:doc-HSBDFCZ5
Image galllery
Abstract
Introduction. CD133 is a marker for a population of glioblastoma (GBM) and normal neural stem cells (NNSC). We aimed to reveal whether the migratory potential and differentiation of these stem cells is associated with CD133 expression and with cathepsin proteases (Cats). Materials and methods. The invasiveness of normal NNSC, GBM/CD133+ cell lines and GBM spheroids was evaluated in 3D collagen, as well as of U87-MG and normal astrocytes (NHA) grown in monolayers in 2D Matrigel. Expression of Cats B, L and S was measuredat mRNA and activity levels and their relation to invasiveness, to CD133 mRNA in 26 gliomas, and to the survival of these patients. Results. The average yield of CD133+ cells from GBM samples was 9.6%. Survival of patients with higher CD133 mRNA expression was significantly shorter (p< 0.005). Invasion, associated with proteolytic degradation of matrix, was higher in normal stem cells and GBM spheroids and cells than in isolated GBM CD133+ cells. In glioma samples, there was no correlation between CD133 mRNA expression and Cat mRNAs, but there was an inverse correlation with Cat activities. Conclusions. The study confirms CD133 as a prognostic marker for the survival of GBM patients. We demonstrated that NNSC have higher invasion potential and invade the collagen matrix in a mode different from that of GBM,initiating stem cell spheres. This result could have implications for the design of new therapeutics, including protease inhibitors that specifically target invasive tumour stem cells. Increased activity of cathepsins in CD133- cells suggests their role in the invasive behaviour of GBM.
Language:
English
Work type:
Not categorized
Typology:
1.01 - Original Scientific Article
Organization:
BF - Biotechnical Faculty
Publisher:
Croatian Medical Association - Croatian Society of Radiology
Year:
2011
Number of pages:
Str. 102-115
Numbering:
Vol. 45, no. 2
PID:
20.500.12556/RUL-55695
UDC:
576
ISSN on article:
1318-2099
DOI:
10.2478/v10019-011-0015-6
COBISS.SI-ID:
28580825
Publication date in RUL:
10.07.2015
Views:
1108
Downloads:
207
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Radiology and oncology
Shortened title:
Radiol. oncol.
Publisher:
Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:
1318-2099
COBISS.SI-ID:
32649472
Secondary language
Language:
English
Title:
[CD133/prominin1 je prognostičen za preživetje bolnikov z glioblastoma, vendar obratno korelira z izražanjem cisteinskih katepsinov]
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back